Simon Sebastian Spahrkäs1, Anne Looijmans1, Robbert Sanderman1,2, Mariët Hagedoorn1. 1. Department of Health Psychology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. 2. Department of Psychology, Health & Technology, University of Twente, Enschede, the Netherlands.
Abstract
OBJECTIVE: This waiting-list randomized controlled trial examined the effectiveness of a self-management mHealth app in improving fatigue and quality of life (QoL) in cancer patients and survivors. METHODS:Persons with cancer-related fatigue (CRF) were recruited across four English speaking countries, via social media, and randomized into intervention (n = 519) and control (n = 280) groups. Whereas the intervention group received immediate access to the Untire app, the control group received access only after 12-weeks. Primary outcomes fatigue severity and interference, and secondary outcome QoL were assessed at baseline, 4, 8, and 12-weeks. We ran generalized linear mixed models for all outcomes to determine the effects of app access (yes/no), over 12-weeks, following the intention-to-treat principle. RESULTS: Compared with the control group, the intervention group showed significantly larger improvements in fatigue severity (d = 0.40), fatigue interference (d = 0.35), and overall QoL on average (d = 0.32) (P's < .01), but not for overall QoL in the past week (P = .07). Sensitivity analyses indicated that participants with medium or high app use benefited most when compared with nonusers and control participants (P's ≤ .02). The intervention effect on fatigue interference was slightly stronger in younger participants (≤56 vs. >56). Effects did not depend on education and cancer status. Reliable change analyses indicated that significantly more people showed full recovery for fatigue in the intervention vs the control group (P's = .02). CONCLUSIONS: The Untire app can be an effective mHealth solution for cancer patients and survivors with moderate to severe CRF.
RCT Entities:
OBJECTIVE: This waiting-list randomized controlled trial examined the effectiveness of a self-management mHealth app in improving fatigue and quality of life (QoL) in cancerpatients and survivors. METHODS:Persons with cancer-related fatigue (CRF) were recruited across four English speaking countries, via social media, and randomized into intervention (n = 519) and control (n = 280) groups. Whereas the intervention group received immediate access to the Untire app, the control group received access only after 12-weeks. Primary outcomes fatigue severity and interference, and secondary outcome QoL were assessed at baseline, 4, 8, and 12-weeks. We ran generalized linear mixed models for all outcomes to determine the effects of app access (yes/no), over 12-weeks, following the intention-to-treat principle. RESULTS: Compared with the control group, the intervention group showed significantly larger improvements in fatigue severity (d = 0.40), fatigue interference (d = 0.35), and overall QoL on average (d = 0.32) (P's < .01), but not for overall QoL in the past week (P = .07). Sensitivity analyses indicated that participants with medium or high app use benefited most when compared with nonusers and control participants (P's ≤ .02). The intervention effect on fatigue interference was slightly stronger in younger participants (≤56 vs. >56). Effects did not depend on education and cancer status. Reliable change analyses indicated that significantly more people showed full recovery for fatigue in the intervention vs the control group (P's = .02). CONCLUSIONS: The Untire app can be an effective mHealth solution for cancerpatients and survivors with moderate to severe CRF.
Authors: Julienne E Bower; Alexandra D Crosswell; Annette L Stanton; Catherine M Crespi; Diana Winston; Jesusa Arevalo; Jeffrey Ma; Steve W Cole; Patricia A Ganz Journal: Cancer Date: 2014-12-23 Impact factor: 6.860
Authors: Eleanor B Tate; Donna Spruijt-Metz; Gillian O'Reilly; Maryalice Jordan-Marsh; Marientina Gotsis; Mary Ann Pentz; Genevieve F Dunton Journal: Transl Behav Med Date: 2013-12 Impact factor: 3.046
Authors: Erin O'Carrol Bantum; Cheryl L Albright; Kami K White; Jeffrey L Berenberg; Gabriela Layi; Phillip L Ritter; Diana Laurent; Katy Plant; Kate Lorig Journal: J Med Internet Res Date: 2014-02-24 Impact factor: 5.428
Authors: Fieke Z Bruggeman-Everts; Marije D J Wolvers; Rens van de Schoot; Miriam M R Vollenbroek-Hutten; Marije L Van der Lee Journal: J Med Internet Res Date: 2017-10-19 Impact factor: 5.428
Authors: Sarah Thomas; Andy Pulman; Huseyin Dogan; Nan Jiang; David Passmore; Keith Pretty; Beth Fairbanks; Angela Davies Smith; Peter W Thomas Journal: JMIR Form Res Date: 2021-12-09